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Xiaoliang Wang 2, Zhennan Ye 1, Lingyun Wu 2, Xiangsheng Zhang 2, Mengliang Zhou 2 and
Hao Pan 2
1Department of Neurosurgery, Jinling Hospital, Clinical Medical College of Southern Medical University (Guangzhou), Nanjing,
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The neuroprotective effect of sinomenine (SIN) has been demonstrated in several brain
injury models. However, its role and molecular mechanism in traumatic brain injury
(TBI) remain unknown. In this study, we investigated the neuroprotective effects of
SIN in the weight-drop model of TBI in male ICR mice. Mice were randomly divided
into the sham and TBI groups, SIN (10mg/kg, 30mg/kg and 50mg/kg, administered
intraperitoneally) or equal volume of vehicle was given at 30 min after TBI. Treatment with
30mg/kg SIN significantly improved motor performance and alleviated cerebral edema.
However, treatment with 10mg/kg or 50mg/kg SIN did not exhibit a better outcome.
Therefore, we chose 30mg/kg SIN for our subsequent experiments. SIN significantly
increased the expression of Bcl-2 and decreased that of cleaved caspase-3, indicating
that SIN is anti-apoptotic. This was confirmed by the observation that SIN-treated animals
had fewer apoptotic neurons. Cortical malondialdehyde content, glutathione peroxidase
(GPx) activity and superoxide dismutase (SOD) activity were restored in the group that
received SIN. Furthermore, Western blot and immunofluorescence experiments showed
that SIN enhanced the translocation of nuclear factor erythroid 2-related factor 2 (Nrf2)
to the nucleus. SIN administration also significantly upregulated the expression of the
downstream factors heme oxygenase 1 and NAD(P)H:quinone oxidoreductase 1 at
pre- and post-transcriptional levels. Together, these data demonstrate that SIN exerts
a neuroprotective effect in a model of TBI, possibly by activating the Nrf2–antioxidant
response element (ARE) pathway.
Keywords: traumatic brain injury, nuclear factor erythroid 2-related factor 2, sinomenine, neuroprotection, reactive
oxygen species
Abbreviations: TBI, traumatic brain injury; Nrf2, nuclear factor erythroid 2-related factor 2; Keap1, Kelch-like ECH-
associated protein 1; SIN, sinomenine; NQO1, NAD(P)H:quinone oxidoreductase 1; HO1, heme oxygenase 1; MDA,
malondialdehyde; GPx, glutathione peroxidase; SOD, superoxide dismutase; ROS, reactive oxygen species; RT-PCR, real-
time quantitative polymerase chain reaction; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling; Bcl-2, B-cell lymphoma 2; CNS, central nervous system; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis; PBS, phosphate buffer solution; PVDF, polyvinylidene fluoride; DAPI, 4′,6-diamidino-2-phenylindole; i.p.,
intraperitoneally.
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INTRODUCTION
Traumatic brain injury (TBI) remains a major public health
problem in modern society, leading to high medical costs,
morbidity and mortality (Zipper and Mulcahy, 2003; Tsai et al.,
2013). The pathological process of TBI involves primary and
secondary injury. After a primary brain insult, a complex
series of endogenous events are triggered, including oxidative
stress, glutamate excitotoxicity, activation of the inflammatory
response, loss of ionic homeostasis, and increased vascular
permeability (Werner and Engelhard, 2007; Bell et al., 2009;
Cornelius et al., 2013), leading to further neuronal degeneration
and apoptosis. These subsequent pathological events are referred
to as secondary brain injury. Despite the efforts focused on
seeking effective ways to alleviate the secondary injury, to date,
most approaches to the treatment of TBI targeting a single injury
mechanism have failed in clinical trials (Sun et al., 2015).
Oxidative stress plays an important role in secondary injury
(Bains and Hall, 2012). It occurs when the production of
reactive oxygen species (ROS) exceeds the cell ability to detoxify.
The excessive production of ROS damages cellular components
including lipids, proteins, and DNA, leading to a decline in
physiological function and cell death (Ansari et al., 2008;
Adibhatla and Hatcher, 2010).
The transcription factor nuclear factor erythroid 2-related
factor 2 (Nrf2) is a key protein in the reduction of oxidative
stress (Yan et al., 2008). Under normal conditions, kelch
ECH associating protein 1 (KEAP1), a cytosolic repressor
protein that binds to Nrf2, retains Nrf2 in the cytosol and
facilitates its proteasomal degradation. Once the cell encounters
stimulations such as oxidative stress, Nrf2 dissociates from
KEAP1 and translocates into the nucleus (de Vries et al.,
2008). By binding to the antioxidant response element (ARE),
Nrf2 induces the production of a battery of endogenous
enzymes, such as superoxide dismutase (SOD), glutathione
peroxidase (GPx), nicotinamide adenine dinucleotide phosphate,
quinine oxidoreductase-1 (NQO1), and heme oxygenase-1
(HO-1). Together, these free radical scavenging enzymes
represent a powerful antioxidant defense mechanism (de Vries
et al., 2008; Ma, 2013). The Nrf2-ARE signaling pathway is
activated in several central nervous system (CNS) diseases,
including TBI (Wang et al., 2007; Chen et al., 2011), and
is considered a protective molecular mechanism against TBI
(Yan et al., 2009).
Sinomenine (7,8-didehydro-4-hydroxy3,7-dimethoxy-17-
methyl-9α, 13α, 14α-morphinan-6-one; SIN) is an active alkaloid
isolated from the Chinese medicinal herb Sinomeniumacutum,
and is used in China for the clinical treatment of rheumatoid
arthritis and mesangial proliferative nephritis (Xu et al.,
2008; Cheng et al., 2013). It has a variety of pharmacological
properties including immunosuppression, anti-inflammation
and cytoprotection (Qian et al., 2007; Cheng et al., 2009;
Wang and Li, 2011). SIN exerts neuroprotection in several
CNS disease models, including cerebral ischemia (Wu et al.,
2011), intracerebral hemorrhage (Yang et al., 2014), and
neurodegenerative diseases (Qian et al., 2007). However, few
studies have addressed the neuroprotective effect of SIN in TBI.
Therefore, the purpose of the present study was to determine
whether SIN administration after TBI could attenuate brain
injury in a TBI model.
MATERIALS AND METHODS
Animals
Male ICR mice weighing 28–32 g were obtained from the
Animal Center of Jinling Hospital. The animals were housed
in a controlled environment with a reversed 12/12 h light/dark
cycle and free access to food and water and were acclimatized
for at least 4 days before any experiment. All procedures
involving animals were approved by the Animal Care and Use
Committee of Southern Medical University, Guangzhou, China,
and conformed to the National Institutes of Health Guide for the
Care and Use of Laboratory Animals.
Model of TBI
The model of TBI used in the present study was based on
Marmarou’s weight-drop model with some modifications as
previously described by Flierl et al. (Flierl et al., 2009; Zhang
et al., 2016). Mice were anesthetized in a closed container on
a wire mesh over ether-soaked cotton and then placed onto
the platform directly under the weight of the weight-drop
device.
The impact area (left anterior frontal region, 1.5mm lateral
to the midline on the midcoronal plane) was located, and a
200 g weight was released and dropped onto the skull from a
height of 2.5 cm. Mortality rate from apnea was reduced by early
respiratory support. The scalp wound was closed with standard
suture material. After recovering from anesthesia, mice were
returned to their cages with food and water provided ad libitum.
Sham-injured animals underwent the same procedure except for
the weight drop.
A total of 214 mice were used in our experiment. No animals
died in the sham-injured group and sham + SIN group. Ten
(TBI, n = 3; TBI + vehicle, n = 3; TBI + 10mg/kg SIN,
n = 1; TBI + 30mg/kg SIN, n = 2; TBI + 50mg/kg SIN,
n = 1) TBI mice died before sacrifice, and the mortality rate
was 6.7%.
Experimental Groups and Drug Treatment
Animals were randomly assigned to the following groups: (1)
sham (n = 42); (2) sham + SIN (50mg/kg i.p.) (n = 12); (3)
TBI (n = 42); (4) TBI + vehicle (n = 42); (5) TBI + SIN
(10mg/kg i.p.) (n = 12); (6) TBI + SIN (30mg/kg i.p.)
(n = 42) and (7) TBI + SIN (50mg/kg i.p.) (n = 12). SIN
was purchased from Sigma-Aldrich (St. Louis, MO) and freshly
prepared in saline containing 1% dimethylsulfoxide (DMSO)
just before injection. Animals in the TBI + SIN and TBI +
vehicle groups received SIN or equal volumes of 1% DMSO,
respectively, 30 min after TBI. Animals in the sham + SIN and
sham + vehicle groups received SIN or vehicle intraperitoneally
30 min after surgery. The mice were sacrificed 24 h after
TBI for biochemical and histological analyses. The doses used
in this study were based on a study of neuroprotection of
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SIN in a middle cerebral artery occlusion model (Wu et al.,
2011).
Neurological Evaluation
Neurological function was evaluated by the grip test which
was developed on the basis of the test of gross vestibulomotor
function as described elsewhere (Bermpohl et al., 2006; Xu et al.,
2014). Briefly, mice were placed on a thin, horizontal, metal
wire (45 cm long) that was suspended between two vertical poles
45 cm above a foam pad and were allowed to traverse the wire for
60 s. The latency that a mouse remained on the wire within a 60-
s interval was measured, and wire grip scores were quantitated
using a 5-point scale (Table 1). The grip test was performed
in triplicate, and a total value was calculated for each mouse.
The test was performed by an investigator who was blinded to
experimental grouping.
Brain Water Content
Brain water content was measured according to a previous study
(Xu et al., 2013). In brief, the brain was removed and placed on a
cooled brainmatrix 24 h after TBI. The brainstem and cerebellum
were removed, and the remaining ipsilateral tissue was weighed
immediately to obtain the wet weight (ww). Then the hemisphere
was dried at 80◦C for 72 h and weighed to obtain the dry weight
(dw). We calculated water content as a percentage using the
following formula: (ww− dw)/ww× 100%.
Tissue Processing
For Western blot and real-time quantitative polymerase chain
reaction (RT-PCR) analysis, animals were anesthetized with
chloral hydrate 24 h after TBI and perfused through the left
cardiac ventricle with 0.9% normal saline solution at 4◦C.
Ipsilateral cerebral cortex tissue 3mm from the margin of
the contusion site was dissected on ice, immediately frozen
in liquid nitrogen, and stored at −80◦C until use. For
immunofluorescence staining and terminal deoxynucleotidyl
transferase-mediated biotinylated deoxyuridine triphosphate
nickend labeling (TUNEL), after being deeply anesthetized
with chloral hydrate 24 h after TBI, animals were perfused
with 0.9% normal saline solution followed by 4% buffered
paraformaldehyde, and the brains were immersed in 4% buffered
paraformaldehyde overnight (all at 4◦C).
TABLE 1 | Behavior scores.
Behavior Points
Unable to remain on the wire for less than 30 s 0
Failed to hold on to the wire with both fore paws and hind paws
together
1
Held on to the wire with both fore paws and hind paws but not the tail 2
Used its tail along with both fore paws and both hind paws 3
Moved along the wire on all four paws plus tail 4
Scored four points also ambulated down one of the posts used to
support the wire
5
Determination of Malondialdehyde (MDA),
Superoxide Dismutase (SOD), and
Glutathione Peroxidase (GPx)
Tissue samples were homogenized in 2ml of phosphate
buffer (10mM; pH 7.4). After centrifugation at 12,000 rpm
for 15 min at 4◦C, MDA, SOD, and GPx content in the
supernatant was measured using a spectrophotometer (Nanjing
Jiancheng Biochemistry Co., Nanjing, China) according to
the manufacturer’s instructions. Protein concentrations were
determined using the Bradford method. MDA content was
expressed as nmol/mg protein, and SOD and GPx activity were
expressed as U/mg protein.
Tunel Analysis
Apoptosis was determined using TUNEL, and included analysis
of DNA fragmentation assays based on 3H-thymidine and
5-bromo-2-deoxyuridine (In Situ Cell Death Detection Kit,
TMR red; Sigma-Aldrich), according to the manufacturer’s
instructions. The slides were then washed with PBST three
times for 30 min prior counterstaining with 4′,6-diamidino-2-
phenylindole (DAPI) for 15 min. After three more washes, the
slides were coverslipped with anti-fade mounting medium for
further study. The TUNEL-positive cells were counted by an
observer who was blind to the experimental groups. To evaluate
the extent of cell apoptosis, the apoptotic index was defined as the
average number of TUNEL-positive cells in each section counted
in six microscopic fields.
Total/Nuclear Protein Extraction and
Western Blot Analysis
Proteins were extracted using the Nuclear and Cytoplasmic
Protein Extraction Kit (Beyotime Biotech Inc., Nantong, China)
according to the kit instructions, and protein concentrations
were determined using the Bradford method. Equal amounts
of protein per lane (50µg) were separated by 10 or 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred to polyvinylidene-difluoride membranes (Millipore,
Bedford, MA, USA). The membranes were incubated in
blocking buffer (Tris buffered saline/0.05% Tween 20 [TBST]
containing 5% skim milk) for 2 h at room temperature,
then overnight at 4◦C with primary antibodies (all raised
in rabbit), as follows: anti-Nrf2, anti-HO-1 and anti-NQO-1
(1:1000, all from Abcam, Cambridge, MA, USA), anti-Bcl-2
(1:200, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
cleaved caspase-3 and anti-Histone 3 (1:1000, Cell Signaling
Technology, Beverly, MA, USA), anti-β-actin (1:5000, Bioworld
Technology, St. Louis Park, MN, USA). After three 10 min
washes with TBST, themembranes were incubated with goat anti-
rabbit horseradish peroxidase (HRP)-conjugated IgG (1:5000,
Bioworld Technology) for 2 h at room temperature. Protein
bands were visualized by enhanced chemiluminescence western
blot detection reagents (Millipore) and quantification was
performed by optical density methods using ImageJ software
(NIH). Proteins of interest were normalized to β-actin or
histone 3.
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qRT-PCR
Total RNA was extracted from the ipsilateral cortex with
RNAiso Plus (Takara Bio, Dalian, China). The concentration and
purity of total RNA were determined with a spectrophotometer
(OD260/280 1.8–2.0) and 1% agarose gel electrophoresis. To
avoid RNA degradation, some of the RNA was immediately
reverse-transcribed to cDNA using the PrimeScript RT
reagent kit (Takara Bio); surplus RNA was kept at 80 ◦C.
The primers were designed according to PubMed GenBank
and synthesized by Invitrogen Life Technologies (Shanghai,
China). The sequences were as follows: NQO1: F, 5′-
CATTCTGAAAGGCTGGTTTGA-3′; R, 5′-CTAGCTTTG
ATCTGGTT-GTCAG-3′; OH-1: F, 5′-ATCGTGCTCGCAT
GAACACT-3′; R, 5′-CCAACACTGC-ATTTACATGGC-3′;
β-actin: F, 5′-AGTGTGACG-TTGACATCCGTA-3′; R, 5′-G
C-CAGAGCAGTAATCTCCTTCT-3′. qRT-PCR analysis was
performed using the Mx3000P System (Stratagene, San Diego,
CA, USA), applying real-time SYBR Green PCR technology.
All samples were analyzed in triplicate. β-actin was used as an
endogenous reference “housekeeping” gene.
Immunofluorescence for Nrf2
Cryostat frozen sections (8µm thick) were mounted on gelatin-
coated slides, which were warmed at room temperature for
30 min. Slides were washed three times in PBS for 10 min
each time before immunofluorescence staining. Based on the
established immunostaining protocol, slides were incubated in
blocking buffer (10% normal goat serum in PBS containing 0.1%
Triton X-100) for 2 h followed by overnight incubation at 4◦C
with rabbit anti-Nrf2 (1:100, Abcam) and anti-NeuN (1:100,
Millipore). The next day, after three more 5 min washes in PBS,
the slides were incubated with appropriate secondary antibodies
(Alexa Fluor 488, 1:200) for 2 h at room temperature. The slides
were washed three times in PBS, counterstained with DAPI
for 2 min, rinsed with PBS, and coverslipped with mounting
medium. Fluorescence microscopy imaging was performed using
a Zeiss HB050 inverted microscope system and handled by
Image-Pro Plus 6.0 software (Media Cybernetics, USA) and
Adobe Photoshop CS5 (Adobe Systems, USA). The specificity
of the immunofluorescence reaction was confirmed using a
negative control in which the primary antibody was replaced
with PBS. Six random fields of vision (200×) were chosen for
each coronal section. Four sections from each animal were
used for quantification. The final average number of positive
cell in the four sections was used as the data for each sample.
Data are presented as the mean fluorescence intensity per 200×
magnification field. The entire process was conducted by two
pathologists blinded to the grouping.
Statistical Analysis
All data used for statistical analysis are expressed as the mean ±
SEM. One-way ANOVA and Tukey’s test were used to analyze
differences between groups except for the neurobehavioral scores,
which were analyzed using nonparametric tests (Kruskal–Wallis
followed by Dunn’s test). SPSS 20.0 was used for statistical
analysis (IBM Corp., Armonk, NY, USA). Statistical significance
was inferred at P < 0.05.
RESULTS
SIN Improves Recovery of Motor
Performance and Alleviates Cerebral
Edema after TBI
To examine whether SIN provides neuroprotection after TBI,
animals were grouped as follows: (1) sham; (2) sham + SIN
(50mg/kg); (3) TBI; (4) TBI+ vehicle; (5) TBI+ SIN (10mg/kg);
(6) TBI + SIN (30mg/kg) and (7) TBI + SIN (50mg/kg). Motor
performance was evaluated using the grip test 1 day, 3 and 7 days
after TBI. All animals were trained on the task 24 h before TBI.
The sham group showed no difference between different time
points and there was no difference between the TBI group and the
vehicle-treated group. All groups exhibited an improved motor
performance over time after TBI. Within 3 days after TBI, the
performance of the groups that received SIN was significantly
better than those that received vehicle. Larger doses such as
50mg/kg, however, did not exhibit a better outcome than 30
mg/kg (P > 0.05; Figure 1A).
We then measured brain water content to confirm the
neuroprotective effect of SIN. Brain water content after TBI
was markedly lower in all three SIN-treated groups than in
animals that received vehicle (P < 0.01, P < 0.001, and
P < 0.01, for 10, 30, and 50mg/kg, respectively; Figure 1B).
Consistent with the grip test, the 30mg/kg dose had a slightly,
but not significantly, greater effect in reducing TBI-induced
brain edema than the other doses (P > 0.05; Figure 1B). These
data confirm that SIN is neuroprotective against TBI, 30mg/kg
provided better recovery when comparing the results of these
two tests, maybe in further tests other doses would have different
dynamics. Therefore, we used this dose in the subsequent
studies.
Sinomenine Administration Attenuated
Neuronal Apoptosis in the Brain after TBI
To determine whether the neuroprotective effects of SIN
can be detected at a histopathological level, NeuN/TUNEL
double immunofluorescence staining was performed to evaluate
neuronal apoptosis. The total number of TUNEL and NeuN
double-stained cells was significantly greater in the TBI and
TBI + vehicle groups 24 h after TBI (Figures 2A,B). However,
the number of TUNEL-positive neurons was reduced after
treatment with SIN. To investigate the effect of SIN on neuronal
apoptosis, we have measured expression of the apoptosis-
related proteins Bcl-2 and the level of cleaved caspase-3. Bcl-
2 is a major anti-apoptotic member of the Bcl-2 family, and
protects cells against a variety of insults such as exposure to
calcium ionophores, glutamate, free radicals and withdrawal
of trophic factors (Reed, 1998; Strauss et al., 2004). Cleaved
caspase-3 is an essential component of the apoptotic machinery
in many cell types (Yuan and Yankner, 2000; Engel et al.,
2011).
Bcl-2 expression was lower in the TBI and TBI + vehicle
groups than in the sham group 24 h after TBI, but elevated after
SIN administration (Figure 2C). Content of cleaved caspase-3
was elevated in the TBI and TBI + vehicle groups and reduced
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FIGURE 1 | SIN protects against secondary brain injury in a mice model of TBI. Mice were subjected to TBI and then received 10, 30, and 50mg/kg of SIN or
vehicle (dimethyl sulfoxide) 30 min later. Grip test score were examined at 1 day, 3 days, and 7 days after TBI while brain water content were evaluated at 1 day after
TBI. (A) Within 3 days after TBI, performance of the 10 and 30mg/kg SIN-treated groups was significantly better than in the vehicle group; however, there was no
significant difference between the 50mg/kg group and the vehicle group. This effect was no longer significant 7 days after TBI between all groups treated with different
doses of SIN and the vehicle-treated group. n = 6 per group. (B) Brain water content was significantly greater in the TBI and TBI + vehicle groups than in the sham or
sham + SIN groups. SIN significantly attenuated brain water content compared with the TBI+vehicle group, with no significant difference between doses. n = 6 per
group. Data are presented as mean ± SEM. **P < 0.01 vs. sham; ***P < 0.001 vs. sham; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. TBI + vehicle group. TBI,
qtraumatic brain injury; SIN, sinomenine.
after treatment with SIN (Figure 2D). These data demonstrate
that SIN successfully inhibited neuronal apoptosis induced
by TBI.
SIN Attenuates Oxidative Stress Caused
by TBI
To evaluate whether the neuroprotective effect of SIN was
derived from its ability to reduce TBI-induced oxidative stress,
levels of MDA, GPx and SOD, indicators of lipid peroxidation
and antioxidant enzyme activity, were measured in brain tissue.
The TBI + vehicle group had a higher level of MDA than
the sham group (P < 0.001) (Figure 3A), and there was no
difference between the TBI and TBI+ vehicle groups (P > 0.05).
However, the level of cortical MDA in mice treated with SIN was
significantly lower than in the TBI + vehicle group (P < 0.001)
(Figure 3A). Activity of GPx and SOD, antioxidant enzymes
responsible for scavenging metabolites generated by free radicals,
was significantly lower after TBI than after sham injury (both
P < 0.001), whereas the SIN-treated group showed significant
upregulation of GPx and SOD activity (P < 0.05 and P < 0.01,
respectively) (Figures 3B,C).
SIN Markedly Promotes Translocation of
Nrf2 from Cytoplasm to the Nucleus in the
Cortex at 24h after TBI
The data obtained demonstrated that SIN has significantly
reversed the parameters of oxidative stress induced by TBI
(Figure 3). Because Nrf2 is a key protein in the reduction
of oxidative stress, it was reasonable to hypothesize that
SIN might activate Nrf2, thereby enhancing the activity of
the antioxidant enzymes. Compared with the sham-injured
group, both TBI and SIN administration induced Nrf2 nuclear
translocation (Figure 4A). In addition, the SIN-treated group
showed significantly greater nuclear expression of Nrf2, and
lower cytoplasmic expression, than the TBI group that received
vehicle (P < 0.01 and P < 0.001, respectively; Figure 4A), which
demonstrated that Nrf2 was activated and SIN promoted Nrf2
nuclear translocation.
This effect was confirmed by immunofluorescence. Nrf2
expression in the sham-injured group was weak compared
with the TBI or vehicle-treated groups and was predominately
detected in the neuronal cytoplasm. Compared with the sham-
injured group, there were more Nrf2-immunoreactive neurons
in the TBI and vehicle-treated groups, with some translocation
of Nrf2 from the cytoplasm to the nucleus being observed. In
the SIN-treated group, there was more Nrf2-immunoreactivity
detected in cell nuclei 24 h after TBI than in the vehicle group
(Figure 4B). Together, this provides abundant evidence that
SIN promotes Nrf2 translocation from the cytoplasm to the
nucleus, thus improving its ability to bind to downstream
genes.
SIN Upregulates the Expression of Nrf2
Downstream Factors
Because SIN was able to activate Nrf2 and provide
neuroprotection against TBI, we hypothesized that it might
also regulate downstream factors in the Nrf2 pathway. We
therefore measured the expression of NQO-1 and HO-1. At
the protein level, NQO-1 and HO-1 were both upregulated
after TBI (P < 0.001 and P < 0.05, respectively; Figure 5A).
Additionally, administration of SIN further enhanced protein
expression compared with vehicle (P < 0.05 and P < 0.001,
respectively; Figure 5A). At the mRNA level, consistent
with the protein changes, SIN enhanced the expression of
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FIGURE 2 | SIN treatment attenuated TBI-induced neuronal apoptosis 24h after TBI. (A) Representative TUNEL staining of brain sections of sham, TBI,
vehicle-treated and SIN-treated mice at 24 h post-injury. (B) SIN treatment significantly decreased the number of TUNEL-positive neurons after TBI. Quantification
showed that SIN-treated mice had significantly fewer TUNEL-positive neurons than the vehicle-treated mice. Representative immunoblots showing the protein levels
of Bcl-2 (C) and cleaved caspase-3 (D) in the sham, TBI, TBI+vehicle, and TBI+SIN groups at 24 h after TBI. n = 6 per group. Data are presented as mean ± SEM.
*P < 0.05 and ***P < 0.001 vs. sham group, #P < 0.05, and ###P < 0.001 vs. TBI + vehicle group.
NQO-1 and HO-1 compared with vehicle (both P < 0.01;
Figure 5B). These results demonstrate that SIN induced
the expression of factors downstream of Nrf2 in terms of
protein and mRNA levels, via activation of the Nrf2 and
the Antioxidant Responsive Element (Nrf2-ARE) signaling
pathway.
DISCUSSION
In the present study, we evaluated the neuroprotective effects
of SIN on TBI-induced brain injury in a mouse model and
the underlying molecular mechanisms. The main findings of
this study are as follows. (1) Administration of SIN improved
neurological function, alleviated cerebral edema, and inhibited
neuronal apoptosis. (2) SIN mitigated TBI-induced oxidative
stress, which is represented by the level of MDA and the activity
of GPx and SOD. (3) The translocation of Nrf2 from the
cytoplasm to the nucleus after TBI, and SIN further promoted
this translocation, subsequently increased the expression of
downstream factors on mRNA and protein levels. These results
suggest that SIN provides neuroprotection in a mouse model of
TBI via the Nrf2-ARE pathway.
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FIGURE 3 | SIN reduces oxidative stress in brain tissue following TBI. (A–C) Oxidative stress was evaluated by the level of malondialdehyde (MDA) and the
activities of glutathione peroxidase (GPx) and superoxide dismutase (SOD). Mice were subjected to TBI and then treated with SIN (30 mg/kg) or vehicle 30 min after
TBI. As shown, (A) the level of MDA in the cortex increased remarkably 24 h after TBI. SIN treatment significantly suppressed the production of MDA after TBI. (B,C)
The activities of GPx and SOD were decreased after TBI, while SIN treatment increased the activities of GPx and SOD. n = 6 per group. Data are presented as
mean ± SEM. ***P < 0.001 vs. sham group, #P < 0.05, ##P < 0.01 vs. TBI + vehicle group.
FIGURE 4 | SIN promoted translocation of Nrf2 from cytoplasm to the nucleus. (A) Mice brain tissues were collected 1 day after TBI in different groups and the
Nrf2 levels in both cytoplasm and nucleus were measured by Western blot. SIN significantly increased the level of Nrf2 in the nucleus and decreased the level of Nrf2
in the cytoplasm. (B) Representative immunofluorescence staining of Nrf2 after SIN treatment in mice with TBI. Double immunofluorescence analysis was performed
with Nrf2 antibodies (red) and neuronal marker (green), and nuclei were fluorescently labeled with DAPI (blue). Scale bar = 20µm. n = 6 per group. Data are
presented as mean ± SEM. **P < 0.01 and ***P < 0.001 vs. sham group; ##P < 0.01 and ###P < 0.001 vs. TBI + vehicle group.
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FIGURE 5 | SIN upregulated the expression of Nrf2 downstream factors
in mice at both protein and mRNA levels. Mice were subjected to TBI and
treated with vehicle or SIN (30 mg/kg) 30 min after TBI. Protein and mRNA
expression was measured by Western blot and RT-PCR, respectively. (A) Both
HO-1 and NQO-1 proteins were upregulated after TBI; additionally, SIN further
increased their expression in brain tissue. Actin was used as a loading control.
Relative intensity means NQO-1 or HO-1/β-actin. (B) NQO-1and HO-1 mRNA
were elevated after TBI and were further increased with administration of SIN.
n = 6 per group. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01,
and ***P < 0.001 vs. sham group; nsP > 0.05 vs. TBI group; #P < 0.05,
##P < 0.01 and ###P < 0.001 vs. TBI + vehicle group.
Secondary brain injury after TBI represents consecutive
pathological processes involving oxidative stress, glutamate
excitotoxicity, loss of ionic homeostasis, inflammatory response,
and increased vascular permeability (Werner and Engelhard,
2007; Bell et al., 2009; Cornelius et al., 2013). Accumulating
evidence shows that oxidative stress is a crucial contributor to the
pathophysiology of TBI and mediates subsequent histopathology
and neurobehavioral deficits (Bains and Hall, 2012). The
enhanced production of reactive oxygen and nitrogen species
though several different cellular pathways plays a pivotal role
in TBI (Lewén et al., 2000; Cornelius et al., 2013; Radak et al.,
2013). Moreover, these radicals can lead to lipid peroxidation,
protein nitration and oxidation (Ansari et al., 2006), and DNA
damage (Shao et al., 2006; Ansari et al., 2008). Oxidative stress
may be a novel therapeutic target in TBI. MDA levels reflect lipid
peroxidation (Hou et al., 2012; Cornelius et al., 2013), and begin
to increase immediately after TBI, remaining elevated 48 h after
injury (Hou et al., 2012). SOD and GPx are antioxidant enzymes
responsible for scavenging metabolites generated by free radicals,
catalyzing the conversion of peroxides into nontoxic forms
(Miller et al., 2009; Cornelius et al., 2013). GPx is an intracellular
antioxidant enzyme, converting peroxides into nontoxic forms
(Miller et al., 2009; Cornelius et al., 2013). In the present study,
SIN treatment after TBI reduced MDA level and increased GPx
and SOD activity, suggesting that SIN could attenuate TBI-
induced oxidative stress.
Increasing evidence indicates that Nrf2 is indispensable in
the induction of antioxidant enzymes, as revealed in various
CNS conditions (Wang et al., 2007; Yan et al., 2009; Chen et al.,
2011) and Nrf2 and phase II enzymes, such as NQO1 and
HO-1, were activated after TBI (Yan et al., 2008, 2009). Besides,
Nrf2-/- mice exhibited poorer outcomes than the wild-type mice,
while activation of Nrf2 could protect against brain injury after
TBI (Wang et al., 2012). Our results also showed that Nrf2
translocated from the cytoplasm to the nucleus after TBI. These
evidences indicate that activation of the Nrf2–ARE pathway is
beneficial for TBI.
SIN has been shown to exert neuroprotection in several
CNS disease models. Zhao and colleagues (Yang et al., 2014)
reported that SIN attenuates brain injury from intracerebral
hemorrhage by inhibiting activation of microglia. Wu et al.
(2011) demonstrated that SIN is potently neuroprotective against
ischemic brain injury when administered before or after the
injury. In a recent study, Qin et al. (2016) showed that SIN
upregulates Nrf2 and phase-II enzymes to exert renoprotective
effects in mouse fibrotic kidney. We therefore hypothesized that
SIN could also activate the Nrf2-ARE pathway in the brain
after TBI to alleviate brain injury by inhibiting oxidative stress
secondary to the upregulation of antioxidant enzymes. In the
present study, we investigated the changes in the Nrf2-ARE
signaling pathway after SIN administration. The data showed
that Nrf2 translocated from the cytoplasm to the nucleus after
TBI, and SIN further promoted this translocation. Compared
with the TBI and TBI + vehicle groups, SIN administration
also significantly upregulated the expression of HO-1 and NQO1
at the pre- and post-transcriptional levels 24 h after TBI. HO-
1 and NQO1 are potent antioxidant and detoxifying enzymes.
HO-1 protects against a number of pathophysiological insults
including oxidative stress (Miller et al., 2009). NQO1 is able
to protect cells against the adverse effects of quinones and
related compounds (Radjendirane et al., 1998). Accordingly,
SIN administration reduced the oxidant damage and alleviated
brain injury in the TBI models in this study. However, the
mechanism of activation of the Nrf2–ARE pathway by SIN has
not been completely elucidated. A number of kinases, such
as phosphoinositol-3 kinase and extracellular signal-regulated
protein kinase reportedly phosphorylate Nrf2 directly and affect
its cellular location or stability in response to some stimuli
(Zipper and Mulcahy, 2003; Tsai et al., 2013). Furthermore,
protein kinase C (PKC) could disrupt the interaction between
Nrf2 and KEAP1 by directing phosphorylation of Nrf2 (Huang
et al., 2000). These mechanisms may be involved in the activation
of the Nrf2–ARE pathway by SIN after TBI, and need to be
investigated in future studies.
Our study has several limitations. First, SIN was only
administered once; we do not know whether multiple treatments
with different time courses would be as effective. Regarding the
clinic application, the therapeutic window of 30 min which was
employed in this study is narrow. Thus, other time points later
than 30 min post-TBI should be tested. Second, SIN may have
other protective effects against TBI that were not evaluated in
this study, such as anti-inflammatory and immunomodulatory
properties. Lastly, we did not use Nrf2 gene knockout mice,
which would confirm whether the observed effects of SIN are due
to activation of the Nrf2–ARE pathway. Further comprehensive
studies are warranted.
CONCLUSION
To the best of our knowledge, the present study is the
first to demonstrate the effects of SIN on the Nrf2–ARE
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signaling pathway in a model of TBI. Our data show that
SIN treatment 30 min after TBI ameliorates secondary brain
injury by improving neurologic function, reducing brain edema,
combating oxidative stress and attenuating neuronal apoptosis.
These effects might correlated with translocation of Nrf2 from
the cytoplasm to the nucleus and activation of downstream
proteins.
AUTHOR CONTRIBUTIONS
YY: Designed the study, performed the TBI model and
biochemical analysis and wrote the manuscript. LL and
XL: Prepared the drug solutions and performed histological
examination. QW, HD, and XW: Performed the TUNEL staining
and the animal studies. ZY, LW, and XZ: Contributed to the
Western blotting. MZ and HP: Designed the animal studies. HW:
Contributed to the design and analysis of the study and wrote
the manuscript. All authors approved the final version of the
manuscript.
ACKNOWLEDGMENTS
This study was grant-supported by the National Natural Science
Fund of China (grant Nos. 81371357 and 81401026).
REFERENCES
Adibhatla, R. M., and Hatcher, J. F. (2010). Lipid oxidation and peroxidation
in CNS health and disease: from molecular mechanisms to therapeutic
opportunities. Antioxid. Redox Signal. 12, 125–169. doi: 10.1089/ars.2009.2668
Ansari, M. A., Joshi, G., Huang, Q., Opii, W. O., Abdul, H. M., Sultana, R., et al.
(2006). In vivo administration of D609 leads to protection of subsequently
isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced
by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer’s
disease and other oxidative stress-related neurodegenerative disorders. Free
Radic. Biol. Med. 41, 1694–1703. doi: 10.1016/j.freeradbiomed.2006.09.002
Ansari, M. A., Roberts, K. N., and Scheff, S. W. (2008). A time course of contusion-
induced oxidative stress and synaptic proteins in cortex in a rat model of TBI.
J. Neurotrauma 25, 513–526. doi: 10.1089/neu.2007.0451
Bains, M., and Hall, E. D. (2012). Antioxidant therapies in traumatic
brain and spinal cord injury. Biochim. Biophys. Acta 1822, 675–684.
doi: 10.1016/j.bbadis.2011.10.017
Bell, J. D., Park, E., Ai, J., and Baker, A. J. (2009). PICK1-mediated GluR2
endocytosis contributes to cellular injury after neuronal trauma. Cell Death
Differ. 16, 1665–1680. doi: 10.1038/cdd.2009.106
Bermpohl, D., You, Z., Korsmeyer, S. J., Moskowitz, M. A., and Whalen,
M. J. (2006). Traumatic brain injury in mice deficient in Bid: effects on
histopathology and functional outcome. J. Cereb. Blood Flow Metab. 26,
625–633. doi: 10.1038/sj.jcbfm.9600258
Chen, G., Fang, Q., Zhang, J., Zhou, D., andWang, Z. (2011). Role of the Nrf2-ARE
pathway in early brain injury after experimental subarachnoid hemorrhage.
J. Neurosci. Res. 89, 515–523. doi: 10.1002/jnr.22577
Cheng, Y., Li, F., Wang, D., Zhang, Y., Yuan, F., and Zhang, J. (2013). Sinomenine
inhibits the expression of PDL1 in the peripheral blood mononuclear cells of
mesangial proliferative nephritis patients.Mol. Med. Rep. 7, 1223–1228. doi: 10.
3892/mmr.2013.1302
Cheng, Y., Zhang, J., Hou, W., Wang, D., Li, F., Zhang, Y., et al. (2009).
Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and
Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis.
Int. Immunopharmacol. 9, 894–899. doi: 10.1016/j.intimp.2009.03.014
Cornelius, C., Crupi, R., Calabrese, V., Graziano, A., Milone, P., Pennisi, G., et al.
(2013). Traumatic brain injury: oxidative stress and neuroprotection. Antioxid.
Redox Signal. 19, 836–853. doi: 10.1089/ars.2012.4981
de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J., Drukarch, B.,
Hoozemans, J., et al. (2008). Nrf2-induced antioxidant protection: a promising
target to counteract ROS-mediated damage in neurodegenerative disease.
Free Radic. Biol. Med. 45, 1375–1383. doi: 10.1016/j.freeradbiomed.2008.
09.001
Engel, T., Plesnila, N., Prehn, J. H., and Henshall, D. C. (2011). In vivo
contributions of BH3-only proteins to neuronal death following seizures,
ischemia, and traumatic brain injury. J. Cereb. Blood Flow Metab. 31,
1196–1210. doi: 10.1038/jcbfm.2011.26
Flierl, M. A., Stahel, P. F., Beauchamp, K. M., Morgan, S. J., Smith, W. R., and
Shohami, E. (2009). Mouse closed head injury model induced by a weight-drop
device. Nat. Protoc. 4, 1328–1337. doi: 10.1038/nprot.2009.148
Hou, Z., Luo, W., Sun, X., Hao, S., Zhang, Y., Xu, F., et al. (2012).
Hydrogen-rich saline protects against oxidative damage and cognitive
deficits after mild traumatic brain injury. Brain Res. Bull. 88, 560–565.
doi: 10.1016/j.brainresbull.2012.06.006
Huang, H. C., Nguyen, T., and Pickett, C. B. (2000). Regulation of the
antioxidant response element by protein kinase C-mediated phosphorylation
of NF-E2-related factor 2. Proc. Natl. Acad. Sci. U.S.A. 97, 12475–12480.
doi: 10.1073/pnas.220418997
Lewén, A., Matz, P., and Chan, P. H. (2000). Free radical pathways in CNS injury.
J. Neurotrauma 17, 871–890. doi: 10.1089/neu.2000.17.871
Ma, Q. (2013). Role of nrf2 in oxidative stress and toxicity. Annu. Rev.
Pharmacol. Toxicol. 53, 401–426. doi: 10.1146/annurev-pharmtox-011112-
140320
Miller, T. W., Isenberg, J. S., and Roberts, D. D. (2009). Molecular regulation
of tumor angiogenesis and perfusion via redox signaling. Chem. Rev. 109,
3099–3124. doi: 10.1021/cr8005125
Qian, L., Xu, Z., Zhang, W., Wilson, B., Hong, J. S., and Flood, P. M.
(2007). Sinomenine, a natural dextrorotatory morphinan analog, is anti-
inflammatory and neuroprotective through inhibition of microglial NADPH
oxidase. J. Neuroinflammation 4:23. doi: 10.1186/1742-2094-4-23
Qin, T., Yin, S., Yang, J., Zhang, Q., Liu, Y., Huang, F., et al. (2016).
Sinomenine attenuates renal fibrosis through Nrf2-mediated inhibition of
oxidative stress and TGFβ signaling. Toxicol. Appl. Pharmacol. 304, 1–8.
doi: 10.1016/j.taap.2016.05.009
Radak, Z., Zhao, Z., Koltai, E., Ohno, H., and Atalay, M. (2013). Oxygen
consumption and usage during physical exercise: the balance between oxidative
stress and ROS-dependent adaptive signaling. Antioxid. Redox Signal. 18,
1208–1246. doi: 10.1089/ars.2011.4498
Radjendirane, V., Joseph, P., Lee, Y. H., Kimura, S., Klein-Szanto, A. J., Gonzalez,
F. J., et al. (1998). Disruption of the DT diaphorase (NQO1) gene in
mice leads to increased menadione toxicity. J. Biol. Chem. 273, 7382–7389.
doi: 10.1074/jbc.273.13.7382
Reed, J. C. (1998). Bcl-2 family proteins. Oncogene 17, 3225–3236.
doi: 10.1038/sj.onc.1202591
Shao, C., Roberts, K. N., Markesbery, W. R., Scheff, S. W., and Lovell, M. A. (2006).
Oxidative stress in head trauma in aging. Free Radic. Biol. Med. 41, 77–85.
doi: 10.1016/j.freeradbiomed.2006.03.007
Strauss, K. I., Narayan, R. K., and Raghupathi, R. (2004). Common patterns of bcl-
2 family gene expression in two traumatic brain injury models. Neurotox. Res.
6, 333–342. doi: 10.1007/BF03033444
Sun, M., Zhao, Y., Gu, Y., and Zhang, Y. (2015). Protective effects of
taurine against closed head injury in rats. J. Neurotrauma 32, 66–74.
doi: 10.1089/neu.2012.2432
Tsai, C. Y., Wang, C. C., Lai, T. Y., Tsu, H. N., Wang, C. H., Liang,
H. Y., et al. (2013). Antioxidant effects of diallyl trisulfide on high
glucose-induced apoptosis are mediated by the PI3K/Akt-dependent
activation of Nrf2 in cardiomyocytes. Int. J. Cardiol. 168, 1286–1297.
doi: 10.1016/j.ijcard.2012.12.004
Wang, B., Zhu, X., Kim, Y., Li, J., Huang, S., Saleem, S., et al. (2012).
Histone deacetylase inhibition activates transcription factor Nrf2 and protects
Frontiers in Neuroscience | www.frontiersin.org 9 December 2016 | Volume 10 | Article 580
Yang et al. Sinomenine Protects against Traumatic Brain Injury
against cerebral ischemic damage. Free Radic. Biol. Med. 52, 928–936.
doi: 10.1016/j.freeradbiomed.2011.12.006
Wang, J., Fields, J., Zhao, C., Langer, J., Thimmulappa, R. K., Kensler, T. W.,
et al. (2007). Role of Nrf2 in protection against intracerebral hemorrhage injury
in mice. Free Radic. Biol. Med. 43, 408–414. doi: 10.1016/j.freeradbiomed.
2007.04.020
Wang, Q., and Li, X. K. (2011). Immunosuppressive and anti-inflammatory
activities of sinomenine. Int. Immunopharmacol. 11, 373–376.
doi: 10.1016/j.intimp.2010.11.018
Werner, C., and Engelhard, K. (2007). Pathophysiology of traumatic brain injury.
Br. J. Anaesth. 99, 4–9. doi: 10.1093/bja/aem131
Wu, W. N., Wu, P. F., Chen, X. L., Zhang, Z., Gu, J., Yang, Y. J., et al.
(2011). Sinomenine protects against ischaemic brain injury: involvement of
co-inhibition of acid-sensing ion channel 1a and L-type calcium channels. Br.
J. Pharmacol. 164, 1445–1459. doi: 10.1111/j.1476-5381.2011.01487.x
Xu, J., Wang, H., Ding, K., Lu, X., Li, T., Wang, J., et al. (2013). Inhibition of
cathepsin S produces neuroprotective effects after traumatic brain injury in
mice.Mediators Inflamm. 2013:187873. doi: 10.1155/2013/187873
Xu, J., Wang, H., Ding, K., Zhang, L., Wang, C., Li, T., et al. (2014).
Luteolin provides neuroprotection in models of traumatic brain
injury via the Nrf2-ARE pathway. Free Radic. Biol. Med. 71, 186–195.
doi: 10.1016/j.freeradbiomed.2014.03.009
Xu, M., Liu, L., Qi, C., Deng, B., and Cai, X. (2008). Sinomenine versus NSAIDs for
the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
Planta Med. 74, 1423–1429. doi: 10.1055/s-2008-1081346
Yan, W., Wang, H. D., Feng, X. M., Ding, Y. S., Jin, W., and Tang, K.
(2009). The expression of NF-E2-related factor 2 in the rat brain after
traumatic brain injury. J. Trauma 66, 1431–1435. doi: 10.1097/TA.0b013e3181
80f5c7
Yan, W., Wang, H. D., Hu, Z. G., Wang, Q. F., and Yin, H. X. (2008). Activation
of Nrf2-ARE pathway in brain after traumatic brain injury. Neurosci. Lett. 431,
150–154. doi: 10.1016/j.neulet.2007.11.060
Yang, Z., Liu, Y., Yuan, F., Li, Z., Huang, S., Shen, H., et al. (2014). Sinomenine
inhibits microglia activation and attenuates brain injury in intracerebral
hemorrhage. Mol. Immunol. 60, 109–114. doi: 10.1016/j.molimm.2014.
03.005
Yuan, J., and Yankner, B. A. (2000). Apoptosis in the nervous system. Nature 407,
802–809. doi: 10.1038/35037739
Zhang, L., Ding, K., Wang, H., Wu, Y., and Xu, J. (2016). Traumatic brain
injury-induced neuronal apoptosis is reduced through modulation of PI3K and
autophagy pathways in mouse by FTY720. Cell. Mol. Neurobiol. 36, 131–142.
doi: 10.1007/s10571-015-0227-1
Zipper, L. M., and Mulcahy, R. T. (2003). Erk activation is required for Nrf2
nuclear localization during pyrrolidine dithiocarbamate induction of glutamate
cysteine ligase modulatory gene expression in HepG2 cells. Toxicol. Sci. 73,
124–134. doi: 10.1093/toxsci/kfg083
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Yang, Wang, Li, Li, Wang, Ding, Wang, Ye, Wu, Zhang, Zhou
and Pan. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 10 December 2016 | Volume 10 | Article 580
